Skip to main content


MDMA-assisted psychotherapy for the treatment of alcohol use disorder was found to improve psychosocial functioning with no unexpected adverse events in a clinical trial conducted by London-based Awakn Life Sciences.
A low dose of naltrexone was found to be a promising alternative to opioids prescribed for patients with orofacial and chronic pain, according to a new study from the University of Michigan School of Dentistry.
With drug overdose deaths reaching historic levels during the COVID-19 pandemic, researchers from the Lerner Center for Public Health Promotion at Syracuse University noted how inconsistent prescribing of anti-anxiety medications has been a significant contributing factor and will continue to be post-pandemic.
The Indiana University School of Medicine has received a $12.3 million grant from the National Institute on Drug Abuse for a two-stage research project to study the use of tezampanel to treat opioid withdrawal syndrome, as well as other addictions and mental illnesses.
Not-for-profit organization Mothers Against Prescription Drug Abuse, life sciences firm Emergent BioSolutions, and three Major League Baseball clubs team up for Overdose Awareness Day initiative.
Back to Top